glp-1 drugs retatrutide for weight loss: Study shows 30% body weight loss PDB-101: Molecule of the Month:

The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease

BPC maintains healthy digestive function and GI lining and has further been proven to enhance cellular repair, angiogenesis, tissue growth, and inflammatory response [1, 2, 3]

However, the -MSH hormone has a very short half-life

Its a warning

The peptide is expected to stay on the Category 2 list because of a lack of clinical evidence and significant safety concerns

Patch is not waterproof